Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
Conclusion:
MTX can prevent CVEs in RA patients, but there is not sufficient evidence for using MTX to treat patients with CHD.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Arthritis | Cardiology | Cardiovascular | Coronary Heart Disease | Databases & Libraries | Heart | Heart Disease | Heart Failure | Internal Medicine | Methotrexate | Rheumatoid Arthritis | Rheumatology | Science | Stroke | Study